The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical

碩士 === 國立屏東教育大學 === 應用數學系 === 99 === This research aims to find out the results taking Xenical for 12 weeks and 24 weeks. The research findings will be discussed in this paper is a path analysis in four exogenous variables (two different hospitals, teams, genders, and the first week data) effect the...

Full description

Bibliographic Details
Main Authors: Hsiao-Feng Hsieh, 謝曉楓
Other Authors: Tien-Lung Tsai
Format: Others
Language:zh-TW
Published: 2011
Online Access:http://ndltd.ncl.edu.tw/handle/se9yjb
id ndltd-TW-099NPTT5507003
record_format oai_dc
spelling ndltd-TW-099NPTT55070032018-04-10T17:13:53Z http://ndltd.ncl.edu.tw/handle/se9yjb The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical 減重與胰島素及代謝症候群因子之路徑分析─以羅氏鮮為例 Hsiao-Feng Hsieh 謝曉楓 碩士 國立屏東教育大學 應用數學系 99 This research aims to find out the results taking Xenical for 12 weeks and 24 weeks. The research findings will be discussed in this paper is a path analysis in four exogenous variables (two different hospitals, teams, genders, and the first week data) effect the metabolism symptom groups which include insulin, triglyceride, low density cholesterol, high density cholesterol, total cholesterol, uric acid, systolic pressure and diastolic pressure. After taking Xenical for 12 weeks, five results will show in this paper. First, taking Xenical is helpful to decrease the BMI, low density cholesterol, total cholesterol and systolic pressure. Second, the finding says the effects in females are better than males. Based upon the data, females can decrease insulin, triglyceride and uric acid. Third, hospital B is better than hospital A in the decrease of BMI. Fourth, hospital A in controlling high density cholesterol is better than hospital B. The data in 12 week will be decreased if you compare with the data in first week. That is, the more you take Xenical, the lower data in four exogenous variables will be demonstrated. Fourth, the less in uric acid you have, and the less high density cholesterol you get. Fifth, if you decrease the BMI, your systolic pressure will also become lower. Taking Xenical for 24 weeks, the research finding shows it gets lower in BMI, low density cholesterol and total cholesterol. Second, the data indicate triglyceride and uric acid in females are lower than males. Third, the insulin in hospital B lower than hospital A. Fourth, hospital A is superior to hospital B in decreasing the high density cholesterol. The data in 24 week are decreasing if you compare with the data in first week. However, two important findings challenge our thinking. One is the more you decrease in BMI, the lower data you get in insulin. The other is the lower you decrease in insulin, the lower data you diminish your uric acid. Tien-Lung Tsai 蔡典龍 2011 學位論文 ; thesis 88 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立屏東教育大學 === 應用數學系 === 99 === This research aims to find out the results taking Xenical for 12 weeks and 24 weeks. The research findings will be discussed in this paper is a path analysis in four exogenous variables (two different hospitals, teams, genders, and the first week data) effect the metabolism symptom groups which include insulin, triglyceride, low density cholesterol, high density cholesterol, total cholesterol, uric acid, systolic pressure and diastolic pressure. After taking Xenical for 12 weeks, five results will show in this paper. First, taking Xenical is helpful to decrease the BMI, low density cholesterol, total cholesterol and systolic pressure. Second, the finding says the effects in females are better than males. Based upon the data, females can decrease insulin, triglyceride and uric acid. Third, hospital B is better than hospital A in the decrease of BMI. Fourth, hospital A in controlling high density cholesterol is better than hospital B. The data in 12 week will be decreased if you compare with the data in first week. That is, the more you take Xenical, the lower data in four exogenous variables will be demonstrated. Fourth, the less in uric acid you have, and the less high density cholesterol you get. Fifth, if you decrease the BMI, your systolic pressure will also become lower. Taking Xenical for 24 weeks, the research finding shows it gets lower in BMI, low density cholesterol and total cholesterol. Second, the data indicate triglyceride and uric acid in females are lower than males. Third, the insulin in hospital B lower than hospital A. Fourth, hospital A is superior to hospital B in decreasing the high density cholesterol. The data in 24 week are decreasing if you compare with the data in first week. However, two important findings challenge our thinking. One is the more you decrease in BMI, the lower data you get in insulin. The other is the lower you decrease in insulin, the lower data you diminish your uric acid.
author2 Tien-Lung Tsai
author_facet Tien-Lung Tsai
Hsiao-Feng Hsieh
謝曉楓
author Hsiao-Feng Hsieh
謝曉楓
spellingShingle Hsiao-Feng Hsieh
謝曉楓
The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
author_sort Hsiao-Feng Hsieh
title The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
title_short The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
title_full The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
title_fullStr The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
title_full_unstemmed The Path Analysis in Weight loss, Insulin, and Metabolic Syndrome Factors ─Based on Xenical
title_sort path analysis in weight loss, insulin, and metabolic syndrome factors ─based on xenical
publishDate 2011
url http://ndltd.ncl.edu.tw/handle/se9yjb
work_keys_str_mv AT hsiaofenghsieh thepathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical
AT xièxiǎofēng thepathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical
AT hsiaofenghsieh jiǎnzhòngyǔyídǎosùjídàixièzhènghòuqúnyīnzizhīlùjìngfēnxīyǐluóshìxiānwèilì
AT xièxiǎofēng jiǎnzhòngyǔyídǎosùjídàixièzhènghòuqúnyīnzizhīlùjìngfēnxīyǐluóshìxiānwèilì
AT hsiaofenghsieh pathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical
AT xièxiǎofēng pathanalysisinweightlossinsulinandmetabolicsyndromefactorsbasedonxenical
_version_ 1718626002697977856